Jamal Zekri

1.3k total citations
68 papers, 945 citations indexed

About

Jamal Zekri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jamal Zekri has authored 68 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Jamal Zekri's work include Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Bone health and treatments (9 papers). Jamal Zekri is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Bone health and treatments (9 papers). Jamal Zekri collaborates with scholars based in Saudi Arabia, Egypt and United Kingdom. Jamal Zekri's co-authors include Barry W. Hancock, S.M.M. Karim, Naglaa S. Ahmed, Nicolas C. Buchs, Pierre D. Delmas, Patrick Garnero, René Rizzoli, Rob Coleman, O.P. Purohit and Ezzeldin M. Ibrahim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Jamal Zekri

62 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamal Zekri Saudi Arabia 14 653 367 190 174 137 68 945
Vito Amoroso Italy 18 711 1.1× 340 0.9× 151 0.8× 82 0.5× 255 1.9× 71 1.1k
L.V.A.M. Beex Netherlands 14 573 0.9× 177 0.5× 146 0.8× 153 0.9× 119 0.9× 33 844
C. Oberhoff Germany 16 454 0.7× 234 0.6× 127 0.7× 165 0.9× 164 1.2× 45 1.1k
Grenville Oades United Kingdom 13 314 0.5× 316 0.9× 231 1.2× 152 0.9× 105 0.8× 30 653
Hadar Goldvaser Israel 15 450 0.7× 185 0.5× 236 1.2× 94 0.5× 381 2.8× 71 899
Maria Cossu Rocca Italy 18 435 0.7× 408 1.1× 149 0.8× 129 0.7× 150 1.1× 70 949
Linda Coate Ireland 13 333 0.5× 343 0.9× 161 0.8× 105 0.6× 140 1.0× 36 756
Patrick Berteloot Belgium 25 741 1.1× 347 0.9× 220 1.2× 176 1.0× 360 2.6× 88 2.0k
Marija Bojić Austria 10 364 0.6× 350 1.0× 283 1.5× 52 0.3× 93 0.7× 39 948

Countries citing papers authored by Jamal Zekri

Since Specialization
Citations

This map shows the geographic impact of Jamal Zekri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Zekri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Zekri more than expected).

Fields of papers citing papers by Jamal Zekri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamal Zekri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Zekri. The network helps show where Jamal Zekri may publish in the future.

Co-authorship network of co-authors of Jamal Zekri

This figure shows the co-authorship network connecting the top 25 collaborators of Jamal Zekri. A scholar is included among the top collaborators of Jamal Zekri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamal Zekri. Jamal Zekri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zekri, Jamal, et al.. (2020). Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria. Breast Care. 15(6). 642–647. 2 indexed citations
3.
Zekri, Jamal, et al.. (2019). Neuroendocrine tumor of the kidney: Diagnostic challenge and successful therapy. Urology Annals. 11(4). 435–435. 2 indexed citations
4.
Zekri, Jamal, et al.. (2018). Obesity and outcome of post-menopausal women receiving adjuvant letrozole for breast cancer. ecancermedicalscience. 12. 821–821. 7 indexed citations
5.
6.
Zekri, Jamal, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 4(7). 14–167.
7.
Zekri, Jamal, et al.. (2016). Assessment of bone health in breast cancer patients starting adjuvant aromatase inhibitors: A quality improvement clinical audit. Journal of bone oncology. 5(4). 159–162. 3 indexed citations
8.
Zekri, Jamal, et al.. (2015). Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement. Journal of Multidisciplinary Healthcare. 8. 335–335. 9 indexed citations
9.
Jazieh, Abdul Rahman, et al.. (2015). Patterns of epidermal growth factor receptor mutation in non-small-cell lung cancers in the Gulf region. Molecular and Clinical Oncology. 3(6). 1371–1374. 22 indexed citations
10.
Zekri, Jamal, et al.. (2014). The anti-tumour effects of zoledronic acid. Journal of bone oncology. 3(1). 25–35. 71 indexed citations
11.
Rordorf, Tamara, Ibrahim A. Hassan, Hamdy A. Azim, et al.. (2014). Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup. The Breast. 23(5). 511–525. 14 indexed citations
12.
Zekri, Jamal, et al.. (2013). Hyperpigmentation of the tongue, palms and soles: Rare side effect of capecitabine. 1(10). 226–229. 10 indexed citations
13.
Bazarbashi, Shouki, et al.. (2011). Saudi Oncology Society clinical management guidelines for urinary bladder cancer. SHILAP Revista de lepidopterología. 3(4). 6–6. 1 indexed citations
14.
Ibrahim, Ezzeldin M., et al.. (2010). Prognostic value of lymph node ratio in poor prognosis node‐positive breast cancer patients in Saudi Arabia. Asia-Pacific Journal of Clinical Oncology. 6(2). 130–137. 12 indexed citations
15.
Zekri, Jamal, et al.. (2008). Epirubicin/Vinorelbine Adjuvant Chemotherapy in Young Women with Breast Cancer is Associated with Preservation of Menstrual Function. Clinical Oncology. 20(7). 513–516. 7 indexed citations
16.
17.
Zekri, Jamal, et al.. (2006). Metastatic Struma Ovarii: Late Presentation, Unusual Features and Multiple Radioactive Iodine Treatments. Clinical Oncology. 18(10). 768–772. 30 indexed citations
18.
Zekri, Jamal, Paul Mouncey, & Barry W. Hancock. (2004). Trials in Advanced Hodgkin's Disease: More than 30 Years Experience of the British National Lymphoma Investigation. Clinical Lymphoma. 5(3). 174–183. 8 indexed citations
19.
Zekri, Jamal, Rachael Hough, J. M. Davies, et al.. (2003). Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma. British Journal of Cancer. 88(9). 1335–1338. 7 indexed citations
20.
Coleman, RE, O.P. Purohit, J. Vinholes, & Jamal Zekri. (1997). High dose pamidronate. Cancer. 80(S8). 1686–1690. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vito Amoroso Breakdown of academic impact, for papers by L.V.A.M. Beex Breakdown of academic impact, for papers by C. Oberhoff Breakdown of academic impact, for papers by Grenville Oades Breakdown of academic impact, for papers by Hadar Goldvaser Breakdown of academic impact, for papers by Maria Cossu Rocca Breakdown of academic impact, for papers by Linda Coate Breakdown of academic impact, for papers by Patrick Berteloot Breakdown of academic impact, for papers by Marija Bojić
Rankless by CCL
2026